Regeneron Pharmaceuticals Inc (REGN)

643.35 -4.83  -0.75% NASDAQ Nov 26, 16:00 USD

Regeneron Pharmaceuticals Revenue (TTM):

13.54B for Sept. 30, 2021
View 4,000+ financial data types
Browse...
View Full Chart

Revenue (TTM) Chart

Export Data
Save Image
Print Image

Historical Revenue (TTM) Data

View and export this data going back to 1990. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 13.54B
June 30, 2021 12.38B
March 31, 2021 9.198B
Dec. 31, 2020 8.497B
Sept. 30, 2020 7.938B
June 30, 2020 7.387B
March 31, 2020 7.013B
Dec. 31, 2019 6.558B
Sept. 30, 2019 5.057B
June 30, 2019 4.976B
March 31, 2019 5.007B
Dec. 31, 2018 5.146B
Sept. 30, 2018 6.365B
June 30, 2018 6.203B
March 31, 2018 6.065B
Dec. 31, 2017 5.872B
Sept. 30, 2017 5.517B
June 30, 2017 5.236B
March 31, 2017 4.979B
Dec. 31, 2016 4.860B
Sept. 30, 2016 4.732B
June 30, 2016 4.649B
March 31, 2016 4.435B
Dec. 31, 2015 4.104B
Sept. 30, 2015 3.808B
   
June 30, 2015 3.396B
March 31, 2015 3.063B
Dec. 31, 2014 2.820B
Sept. 30, 2014 2.628B
June 30, 2014 2.499B
March 31, 2014 2.291B
Dec. 31, 2013 2.105B
Sept. 30, 2013 1.909B
June 30, 2013 1.740B
March 31, 2013 1.586B
Dec. 31, 2012 1.378B
Sept. 30, 2012 1.087B
June 30, 2012 762.00M
March 31, 2012 565.41M
Dec. 31, 2011 445.82M
Sept. 30, 2011 456.52M
June 30, 2011 459.67M
March 31, 2011 467.74M
Dec. 31, 2010 459.07M
Sept. 30, 2010 422.20M
June 30, 2010 433.68M
March 31, 2010 407.82M
Dec. 31, 2009 379.27M
Sept. 30, 2009 338.30M
June 30, 2009 286.43M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Benchmarks

Moderna Inc 11.83B
Gilead Sciences Inc 27.48B
Johnson & Johnson 91.45B

Revenue (TTM) Range, Past 5 Years

Minimum 4.860B Dec 2016
Maximum 13.54B Sep 2021
Average 6.890B

News

Insider Sell: Regeneron Pharmaceuticals
MT Newswires 11/18 07:36 ET
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.